Neuroinflammation in Parkinson’s Disease Animal Models: A Cell Stress Response or a Step in Neurodegeneration?
The DOI matches its Crossref record; 280 of the 282 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The motor symptoms of Parkinson's disease are due to the progressive degeneration of dopaminergic neurons in the substantia nigra. Multiple neuroinflammatory processes are exacerbated in Parkinson's disease, including glial-mediated reactions, increased expression of proinflammatory substances, and lymphocytic infiltration, particularly in the substantia nigra. Neuroinflammation is also implicated in the neurodegeneration and consequent behavioral symptoms of many Parkinson's disease animal models, although it is not clear whether these features emulate pathogenic steps in the genuine disorder or if some inflammatory features provide protective stress responses. Here, we compare and summarize findings on neuroinflammatory responses and effects on behavior in a wide range of toxin-based, inflammatory and genetic Parkinson's disease animal models.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“α-Synuclein modified by ONOO− or oxidized dopamine forms aggregates and Lewy bodies (214) that further activate microglia (211).”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [214]
Citations
Cites
2 retracted
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo
Rockenstein, E., Nuber, S., Overk, C. R., Ubhi, K., Mante, M., Patrick, C., Adame, A., Trejo-Morales, M., Gerez, J., Picotti, P., et al. (2014) · Brain · doi:10.1093/brain/awu057 · Cited by 238
RetractedTobón-Velasco, J. C., Limón-Pacheco, J. H., Orozco‐Ibarra, M., Macías‐Silva, M., Vázquez‐Victorio, G., Cuevas, E., Ali, S. F., Cuadrado, A., Pedraza‐Chaverrí, J., & Santamaría, A. (2012) · Toxicology · doi:10.1016/j.tox.2012.12.011 · Cited by 42
RetractedSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 2×
“SNCA was also the first PD gene identified (Polymeropoulos et al. 1997), and encodes a 140 amino acid synaptic vesicle-associated protein that regulates synaptic vesicle exocytosis (Abeliovich et al.”
BackgroundParkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · cited 2×
“…by a progressive loss of dopamine (DA) releasing neurons in the substantia nigra (SN) pars compacta (SNc), resulting in slowness of movement, rigidity, and tremor (Jankovic 2008), as well as the death of neurons in other catecholaminergic and cholinergic nuclei (Sulzer and Surmeier 2013).”
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“Mutations in the parkin gene, which encodes for an E3 ubiquitin ligase, are the leading cause of early-onset, autosomal recessive parkinsonism (Kitada et al. 1998; Hattori et al. 1998; Lücking et al. 2000).”
Backgroundα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 6×
“LPS did not release IL-1β and NFκB p65, or kill SN neurons in mice deficient for TNF-α receptors (Qin et al. 2007).”
BackgroundInfluentialImpaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“Both unfolded and aggregated might be neurotoxic via a variety of pathways including inhibition of protein degradation by chaperonemediated autophagy (Cuervo et al. 2004) and membrane permeabilization (Rochet et al. 2004; Mosharov et al. 2006; Staal et al. 2008).”
BackgroundSelf-citationNeuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858 · cited 1×
“This assumption was superseded as more recent studies described how cellular BBB permeability is regulated as a stress response (Franzén et al. 2003; Ransohoff and Perry 2009; Rezai-Zadeh et al. 2009).”
BackgroundDrosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 2×
“PINK1-targeted KOs (Kitada et al. 2007; Gispert et al. 2009) and shRNA-mediated knockdown models (Zhou et al. 2007b) did not replicate robust degenerative phenotypes and mitochondrial defects reported in fly models (Clark et al. 2006).”
BackgroundMasliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Self-citationVolpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Conway, K. A., Lee, S.-J., Rochet, J.-C., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,541
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,376
Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein
Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00682-7 · Cited by 1,266
Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs
Olson, J. K., & Miller, S. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3916 · Cited by 1,215
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Luk, K. C., Kehm, V. M., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M. Y. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112457 · Cited by 1,100
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Nemani, V. M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M. K., Chaudhry, F. A., Nicoll, R. A., & Edwards, R. H. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.023 · Cited by 1,056
Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
Shin, J.-H., Ko, H. S., Kang, H., Lee, Y., Lee, Y.-I., Pletinkova, O., Troconso, J. C., Dawson, V. L., & Dawson, T. M. (2011) · Cell · doi:10.1016/j.cell.2011.02.010 · Cited by 953
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308947200 · Cited by 913 · cited 1×
“Several groups have generated parkin KO mice (Goldberg et al. 2003; Itier et al. 2003; Von Coelln et al. 2004).”
BackgroundPrion-like spreading of pathological α-synuclein in brain
Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Oikawa, T., Arai, T., Akiyama, H., Mann, D. M. A., & Hasegawa, M. (2013) · Brain · doi:10.1093/brain/awt037 · Cited by 867 · cited 2×
“Oligomeric α-syn may mediate neurodegeneration by disrupting synaptic vesicles (Rockenstein et al. 2014). α-syn fibrils, like prions, have been shown to seed new α-syn reactions (Miake et al. 2002; Masuda-Suzukake et al. 2013).”
BackgroundMcCoy, M. K., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-45 · Cited by 847
Lee, M. K., Stirling, W., Xu, Y., Xu, X., Qui, D., Mandir, A. S., Dawson, T. M., Copeland, N. G., Jenkins, N. A., & Price, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132197599 · Cited by 824
Genetic Animal Models of Parkinson's Disease
Dawson, T. M., Ko, H. S., & Dawson, V. L. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.034 · Cited by 823
Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP
Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803
Conway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786
Does neuroinflammation fan the flame in neurodegenerative diseases?
Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., & Tansey, M. G. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-47 · Cited by 751
Blood–brain barrier dysfunction in parkinsonian midbrain in vivo
Kortekaas, R., Leenders, K. L., van Oostrom, J. C. H., Vaalburg, W., Bart, J., Willemsen, A. T. M., & Hendrikse, N. H. (2005) · Annals of Neurology · doi:10.1002/ana.20369 · Cited by 733
Sherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100560200 · Cited by 684
Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., & Lee, M. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4308-05.2006 · Cited by 684 · cited 2×
“2005), while mutant A53T mice displayed mitochondrial damage and degeneration (Martin et al. 2006).”
BackgroundDistinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B., Riddle, D. M., Kwong, L. K., Xu, Y., Trojanowski, J. Q., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.057 · Cited by 680
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M. P., Beilina, A., Blackinton, J., Thomas, K. J., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.001 · Cited by 671
Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J., & Björklund, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02780.2002 · Cited by 649
Pycock, C. J. (1980) · Neuroscience · doi:10.1016/0306-4522(80)90048-2 · Cited by 610
Interplay of LRRK2 with chaperone-mediated autophagy
Orenstein, S. J., Kuo, S.-H., Tasset, I., Arias, E., Koga, H., Fernandez-Carasa, I., Cortes, E., Honig, L. S., Dauer, W., Consiglio, A., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3350 · Cited by 588 · cited 2×
“2011) and modulation of chaperone-mediated autophagy (Orenstein et al. 2013), a mechanism that may cause α-syn aggregation.”
BackgroundSelf-citationResistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
Dauer, W., Kholodilov, N., Vila, M., Trillat, A.-C., Goodchild, R., Larsen, K. E., Staal, R., Tieu, K., Schmitz, Y., Yuan, C. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172514599 · Cited by 581
Self-citationQin, L., Liu, Y., Wang, T., Wei, S.-J., Block, M. L., Wilson, B., Liu, B., & Hong, J.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307657200 · Cited by 574 · cited 3×
“…IL-1α, TNF-α, IL-1β, and inducible nitric oxide synthase (iNOS, Qin et al. 2007; Tomás-Camardiel et al. 2004; Hernández-Romero et al. 2008), and increases COX-2 (de Meira Santos Lima et al. 2006; Geng et al. 2011), ROS and matrix metalloproteinase-3 (MMP-3) (Qin et al. 2004; McClain et al. 2009).”
BackgroundImpaired dopamine release and synaptic plasticity in the striatum of PINK1 -deficient mice
Kitada, T., Pisani, A., Porter, D. R., Yamaguchi, H., Tscherter, A., Martella, G., Bonsi, P., Zhang, C., Pothos, E. N., & Shen, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702717104 · Cited by 540
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
Biskup, S., Moore, D. J., Celsi, F., Higashi, S., West, A. B., Andrabi, S. A., Kurkinen, K., Yu, S., Savitt, J. M., Waldvogel, H. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.21019 · Cited by 511
Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse
Itier, J.-M. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg239 · Cited by 508
Neurotoxin-based models of Parkinson's disease
Bové, J., & Perier, C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.057 · Cited by 506
Rockenstein, E., Mallory, M., Hashimoto, M., Song, D., Shults, C. W., Lang, I., & Masliah, E. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10231 · Cited by 502
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein
Fleming, S. M., Salcedo, J., Fernagut, P.-O., Rockenstein, E., Masliah, E., Levine, M. S., & Chesselet, M.-F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3080-04.2004 · Cited by 474
Synuclein activates microglia in a model of Parkinson's disease
Su, X., Maguire-Zeiss, K. A., Giuliano, R., Prifti, L., Venkatesh, K., & Federoff, H. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.006 · Cited by 474 · cited 1×
“Microglial activation and high levels of TNF-α were found in the SN of mice expressing human α-syn under control of the mouse TH promoter (Su et al. 2008).”
BackgroundGlutathione peroxidase, glial cells and Parkinson's disease
Damier, P., Hirsch, E. C., Zhang, P., Agid, Y., & Javoy-Agid, F. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90175-f · Cited by 466
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Moehle, M. S., Webber, P. J., Tse, T., Sukar, N., Standaert, D. G., DeSilva, T. M., Cowell, R. M., & West, A. B. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5601-11.2012 · Cited by 463
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Hong, J.-S., Zhang, W., & Liu, B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439
Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration
Gao, H.-M., Kotzbauer, P. T., Uryu, K., Leight, S., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0143-07.2008 · Cited by 436
Larsen, K. E., Schmitz, Y., Troyer, M. D., Mosharov, E., Dietrich, P., Quazi, A. Z., Savalle, M., Nemani, V., Chaudhry, F. A., Edwards, R. H., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3821-06.2006 · Cited by 415
Self-citationLRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
Gardet, A., Benita, Y., Li, C., Sands, B. E., Ballester, I., Stevens, C., Korzenik, J. R., Rioux, J. D., Daly, M. J., Xavier, R. J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000548 · Cited by 415
Reynolds, A. D., Stone, D. K., Hutter, J. A. L., Benner, E. J., Mosley, R. L., & Gendelman, H. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901852 · Cited by 406
Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J., Raman, C., & Standaert, D. G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5610-12.2013 · Cited by 406
Cicchetti, F., Brownell, A. L., Williams, K., Chen, Y. I., Livni, E., & Isacson, O. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01938.x · Cited by 406
Kirik, D., Annett, L. E., Burger, C., Muzyczka, N., Mandel, R. J., & Björklund, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0536383100 · Cited by 403
McGeer, P. L., Schwab, C., Parent, A., & Doudet, D. (2003) · Annals of Neurology · doi:10.1002/ana.10728 · Cited by 400 · cited 1×
“In non-human primates, HLA-DR-reactive microglia are found in SN following MPTP administration (McGeer et al. 2003).”
BackgroundCastaño, A., Herrera, A. J., Cano, J., & Machado, A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041584.x · Cited by 390
Gispert, S., Ricciardi, F., Kurz, A., Azizov, M., Hoepken, H.-H., Becker, D., Voos, W., Leuner, K., Müller, W. E., Kudin, A. P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005777 · Cited by 381
Mechanism of 6-hydroxydopamine neurotoxicity
Glinka, Y., Gassen, M., & Youdim, M. B. H. (1997) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6842-4_7 · Cited by 380
Kurkowska-Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6993 · Cited by 379
Theodore, S., Cao, S., McLean, P. J., & Standaert, D. G. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818e5e99 · Cited by 367
Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2002) · The FASEB Journal · doi:10.1096/fj.02-0216fje · Cited by 362
Gao, H.-M., Zhang, F., Zhou, H., Kam, W., Wilson, B., & Hong, J.-S. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1003013 · Cited by 355 · cited 1×
“LPS causes neuronal death in transgenic mice that express normal or mutant (A53T) α-syn (Gao et al. 2008, 2011).”
BackgroundKoprich, J. B., Reske-Nielsen, C., Mithal, P., & Isacson, O. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-8 · Cited by 355
McCoy, M. K., Martinez, T. N., Ruhn, K. A., Szymkowski, D. E., Smith, C. G., Botterman, B. R., Tansey, K. E., & Tansey, M. G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1504-06.2006 · Cited by 354
He, Y., Appel, S., & Le, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02681-6 · Cited by 348
Loss of locus coeruleus neurons and reduced startle in parkin null mice
von Coelln, R., Thomas, B., Savitt, J. M., Lim, K. L., Sasaki, M., Hess, E. J., Dawson, V. L., & Dawson, T. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401297101 · Cited by 347
Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model
Janezic, S., Threlfell, S., Dodson, P. D., Dowie, M. J., Taylor, T. N., Potgieter, D., Parkkinen, L., Senior, S. L., Anwar, S., Ryan, B., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309143110 · Cited by 344 · cited 3×
“Cellular and Cytokine Responses A number of SCNA mouse models (KO, overexpressors, and transgenics) have been generated (Chesselet 2008) although few exhibit DA cell loss (for exceptions, see Lin et al. 2012 and Janezic et al. 2013).”
BackgroundGenomic investigation of α‐synuclein multiplication and parkinsonism
Ross, O. A., Braithwaite, A. T., Skipper, L. M., Kachergus, J., Hulihan, M. M., Middleton, F. A., Nishioka, K., Fuchs, J., Gasser, T., Maraganore, D. M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21380 · Cited by 342
Li, X., Patel, J. C., Wang, J., Avshalumov, M. V., Nicholson, C., Buxbaum, J. D., Elder, G. A., Rice, M. E., & Yue, Z. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5604-09.2010 · Cited by 341
Pesticide Exposure and Self-reported Parkinson's Disease in the Agricultural Health Study
Kamel, F., Tanner, C., Umbach, D., Hoppin, J., Alavanja, M., Blair, A., Comyns, K., Goldman, S., Korell, M., Langston, J., et al. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwk024 · Cited by 339
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
Cebrián, C., Zucca, F. A., Mauri, P., Steinbeck, J. A., Studer, L., Scherzer, C. R., Kanter, E., Budhu, S., Mandelbaum, J., Vonsattel, J. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4633 · Cited by 338
Self-citationCritical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Liu, B., & Hong, J.-S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06181.2003 · Cited by 337
Pott Godoy, M. C., Tarelli, R., Ferrari, C. C., Sarchi, M. I., & Pitossi, F. J. (2008) · Brain · doi:10.1093/brain/awn101 · Cited by 335 · cited 2×
“…LPS triggers activation of astrocytes and microglia; damages SN DA neurons (Castaño et al. 1998; Iravani et al. 2005; Qin et al. 2007; Pott Godoy et al. 2008), releases proinflammatory factors including IL-1α, TNF-α, IL-1β, and inducible nitric oxide synthase (iNOS, Qin et al. 2007;…”
BackgroundInhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Lee, B. D., Shin, J.-H., VanKampen, J., Petrucelli, L., West, A. B., Ko, H. S., Lee, Y.-I., Maguire-Zeiss, K. A., Bowers, W. J., Federoff, H. J., et al. (2010) · Nature Medicine · doi:10.1038/nm.2199 · Cited by 329
Tofaris, G. K., Garcia Reitböck, P., Humby, T., Lambourne, S. L., O’Connell, M., Ghetti, B., Gossage, H., Emson, P. C., Wilkinson, L. S., Goedert, M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4965-05.2006 · Cited by 326
DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders
Kahle, P. J., Waak, J., & Gasser, T. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.08.003 · Cited by 324 · cited 1×
“DJ-1 seems to be an important redox-reactive signaling intermediate controlling oxidative stress associated with ischemia, neuroinflammation, and age-related neurodegeneration (Kahle et al. 2009).”
BackgroundSelective microglial activation in the rat rotenone model of Parkinson's disease
Sherer, T. B., Betarbet, R., Kim, J.-H., & Greenamyre, J. T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00172-1 · Cited by 316
Involvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons
Mount, M. P., Lira, A., Grimes, D., Smith, P. D., Faucher, S., Slack, R., Anisman, H., Hayley, S., & Park, D. S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5321-06.2007 · Cited by 315
Neuronal vulnerability, pathogenesis, and Parkinson's disease
Sulzer, D., & Surmeier, D. J. (2013) · Movement Disorders · doi:10.1002/mds.25095 · Cited by 315
Self-citationCicchetti, F., Drouin-Ouellet, J., & Gross, R. E. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.005 · Cited by 311
Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease
Collins, L. M., Toulouse, A., Connor, T. J., & Nolan, Y. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.028 · Cited by 306
Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease
Taylor, J. M., Main, B. S., & Crack, P. J. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.016 · Cited by 303
Hattori, N., Kitada, T., Matsumine, H., Asakawa, S., Yamamura, Y., Yoshino, H., Kobayashi, T., Yokochi, M., Wang, M., Yoritaka, A., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440612 · Cited by 296
Harkavyi, A., Abuirmeileh, A., Lever, R., Kingsbury, A. E., Biggs, C. S., & Whitton, P. S. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-19 · Cited by 289
Pesticide exposure and risk of Parkinson's disease: A family-based case-control study
Hancock, D. B., Martin, E. R., Mayhew, G. M., Stajich, J. M., Jewett, R., Stacy, M. A., Scott, B. L., Vance, J. M., & Scott, W. K. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-6 · Cited by 285
Członkowska, A., Kohutnicka, M., Kurkowska-Jastrzębska, I., & Członkowski, A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0020 · Cited by 279
Neural Activity Controls the Synaptic Accumulation of α-Synuclein
Fortin, D. L., Nemani, V. M., Voglmaier, S. M., Anthony, M. D., Ryan, T. A., & Edwards, R. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2922-05.2005 · Cited by 271
Carrier-mediated processes in blood–brain barrier penetration and neural uptake of paraquat
Shimizu, K., Ohtaki, K., Matsubara, K., Aoyama, K., Uezono, T., Saito, O., Suno, M., Ogawa, K., Hayase, N., Kimura, K., et al. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02577-x · Cited by 263
Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration
Frank-Cannon, T. C., Tran, T., Ruhn, K. A., Martinez, T. N., Hong, J., Marvin, M., Hartley, M., Treviño, I., O'Brien, D. E., Casey, B., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3001-08.2008 · Cited by 261
Biochemical Characterization of the Core Structure of α-Synuclein Filaments
Miake, H., Mizusawa, H., Iwatsubo, T., & Hasegawa, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110551200 · Cited by 260
Zhang, W., Phillips, K., Wielgus, A. R., Liu, J., Albertini, A., Zucca, F. A., Faust, R., Qian, S. Y., Miller, D. S., Chignell, C. F., et al. (2011) · Neurotoxicity Research · doi:10.1007/s12640-009-9140-z · Cited by 257 · cited 3×
“…is provided by inhibiting inflammation with a peroxisome proliferator-activated receptor gamma agonist (Sadeghian et al. 2012), silencing theenzyme inducible nitricoxide synthase (iNOS) (Li et al. 2012)orblocking TNF-α (McCoy et al. 2006; Harms et al. 2011; Pabon et al. 2011; Zhang et al. 2011b).”
BackgroundSelf-citationSanchez-Guajardo, V., Febbraro, F., Kirik, D., & Romero-Ramos, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008784 · Cited by 256
Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration
Purisai, M. G., McCormack, A. L., Cumine, S., Li, J., Isla, M. Z., & Di Monte, D. A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.008 · Cited by 254
Ko, H. S., von Coelln, R., Sriram, S. R., Kim, S. W., Chung, K. K. K., Pletnikova, O., Troncoso, J., Johnson, B., Saffary, R., Goh, E. L., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2172-05.2005 · Cited by 247
Grünblatt, E., Mandel, S., Maor, G., & Youdim, M. B. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00397.x · Cited by 246
Engelhardt, B., & Coisne, C. (2011) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-8-4 · Cited by 246
Watson, M. B., Richter, F., Lee, S. K., Gabby, L., Wu, J., Masliah, E., Effros, R. B., & Chesselet, M.-F. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.025 · Cited by 241
CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson’s disease
Pabon, M. M., Bachstetter, A. D., Hudson, C. E., Gemma, C., & Bickford, P. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-9 · Cited by 241
Castaño, A., Herrera, A. J., Cano, J., & Machado, A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00799.x · Cited by 238
Sanchez-Guajardo, V., Barnum, C. J., Tansey, M. G., & Romero-Ramos, M. (2013) · ASN Neuro · doi:10.1042/an20120066 · Cited by 236
The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery
Dutta, G., Zhang, P., & Liu, B. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00616.x · Cited by 235 · cited 3×
“2002) or neutralizing antibodies against TNF-α or IL-1 that block microglial activation (Dutta et al. 2008; McCoy and Tansey 2008).”
BackgroundSánchez‐Pernaute, R., Ferree, A. W., Cooper, O., Yu, M., Brownell, A., & Ole Isacson, A. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-6 · Cited by 229
Isoquinoline neurotoxins in the brain and Parkinson's disease
Nagatsu, T. (1997) · Neuroscience Research · doi:10.1016/s0168-0102(97)00083-7 · Cited by 229
Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain
Eslamboli, A., Romero-Ramos, M., Burger, C., Bjorklund, T., Muzyczka, N., Mandel, R. J., Baker, H., Ridley, R. M., & Kirik, D. (2007) · Brain · doi:10.1093/brain/awl382 · Cited by 227
Danoy, P., Pryce, K., Hadler, J., Bradbury, L. A., Farrar, C., Pointon, J. J., Ward, M. M., Weisman, M. H., Reveille, J. D., Wordsworth, B. P., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001195 · Cited by 226
Abrogation of α-synuclein–mediated dopaminergic neurodegeneration in LRRK2-deficient rats
Daher, J. P. L., Volpicelli-Daley, L. A., Blackburn, J. P., Moehle, M. S., & West, A. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403215111 · Cited by 223 · cited 1×
“These data suggest that knocking down LRRK2 may protect against SN neuronal loss by inhibiting recruitment of proinflammatory myeloid cells (Daher et al. 2014).”
BackgroundGillardon, F., Schmid, R., & Draheim, H. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.001 · Cited by 222
Marinova‐Mutafchieva, L., Sadeghian, M., Broom, L., Davis, J. B., Medhurst, A. D., & Dexter, D. T. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06189.x · Cited by 217
Dzamko, N., Inesta-Vaquera, F., Zhang, J., Xie, C., Cai, H., Arthur, S., Tan, L., Choi, H., Gray, N., Cohen, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039132 · Cited by 213
Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+
Ransom, B. R., Kunis, D. M., Irwin, I., & Langston, J. W. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90543-x · Cited by 209
Wu, S.-Y., Wang, T.-F., Yu, L., Jen, C. J., Chuang, J.-I., Wu, F.-S., Wu, C.-W., & Kuo, Y.-M. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.09.006 · Cited by 206 · cited 1×
“Blocking BDNF with a TrkB receptor antagonist abolished running’s protective effect, while intrastriatal perfusion of BDNF alone blocked LPS-induced DA neuron loss (Wu et al. 2011).”
BackgroundBarcia, C., Ros, C. M., Annese, V, Gómez, A., Ros-Bernal, F., Aguado-Llera, D., Martínez-Pagán, M. E., de Pablos, V, Fernandez-Villalba, E., & Herrero, M. T. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.17 · Cited by 203
Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia
Kim, B., Yang, M.-S., Choi, D., Kim, J.-H., Kim, H.-S., Seol, W., Choi, S., Jou, I., Kim, E.-Y., & Joe, E.-H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034693 · Cited by 203
Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6
Hoepken, H.-H., Gispert, S., Morales, B., Wingerter, O., Del Turco, D., Mülsch, A., Nussbaum, R. L., Müller, K., Dröse, S., Brandt, U., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.007 · Cited by 203
Gayle, D. A., Ling, Z., Tong, C., Landers, T., Lipton, J. W., & Carvey, P. M. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00315-7 · Cited by 200
CNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease?
Rezai-Zadeh, K., Gate, D., & Town, T. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9166-2 · Cited by 197
Inflammation in Parkinson's Disease
Tufekci, K. U., Meuwissen, R., Genc, S., & Genc, K. (2012) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/b978-0-12-398314-5.00004-0 · Cited by 196
Hinkle, K. M., Yue, M., Behrouz, B., Dächsel, J. C., Lincoln, S. J., Bowles, E. E., Beevers, J. E., Dugger, B., Winner, B., Prots, I., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-25 · Cited by 191
Rochet, J.-C., Outeiro, T. F., Conway, K. A., Ding, T. T., Volles, M. J., Lashuel, H. A., Bieganski, R. M., Lindquist, S. L., & Lansbury, P. T. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:1-2:023 · Cited by 191
Lipopolysaccharide Animal Models for Parkinson's Disease
Liu, M., & Bing, G. (2011) · Parkinson's Disease · doi:10.4061/2011/327089 · Cited by 190
Lin, X., Parisiadou, L., Sgobio, C., Liu, G., Yu, J., Sun, L., Shim, H., Gu, X.-L., Luo, J., Long, C.-X., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1731-12.2012 · Cited by 189
Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats
Cicchetti, F., Lapointe, N., Roberge-Tremblay, A., Saint-Pierre, M., Jimenez, L., Ficke, B. W., & Gross, R. E. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.018 · Cited by 187
In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease?
Chesselet, M.-F. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.08.006 · Cited by 186
Swanson, C. R., Joers, V., Bondarenko, V., Brunner, K., Simmons, H. A., Ziegler, T. E., Kemnitz, J. W., Johnson, J. A., & Emborg, M. E. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-91 · Cited by 186
Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures
Bronstein, D. M., Perez-Otano, I., Sun, V., Mullis Sawin, S. B., Chan, J., Wu, G.-C., Hudson, P. M., Kong, L.-Y., Hong, J.-S., & McMillian, M. K. (1995) · Brain Research · doi:10.1016/0006-8993(95)01189-7 · Cited by 186
Lewy pathology and neurodegeneration in premotor Parkinson's disease
Del Tredici, K., & Braak, H. (2012) · Movement Disorders · doi:10.1002/mds.24921 · Cited by 185
Gomez-Isla, T., Irizarry, M. C., Mariash, A., Cheung, B., Soto, O., Schrump, S., Sondel, J., Kotilinek, L., Day, J., Schwarzschild, M. A., et al. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00091-x · Cited by 178
Limitations of Animal Models of Parkinson's Disease
Potashkin, J. A., Blume, S. R., & Runkle, N. K. (2011) · Parkinson's Disease · doi:10.4061/2011/658083 · Cited by 177
Neuroinflammation in Parkinson’s Disease
Lee, J.-K., Tran, T., & Tansey, M. G. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9176-0 · Cited by 171
Microglial response to 6-hydroxydopamine-induced substantia nigra lesions
Akiyama, H., & McGeer, P. L. (1989) · Brain Research · doi:10.1016/0006-8993(89)90857-3 · Cited by 169
Fai Poon, H., Frasier, M., Shreve, N., Calabrese, V., Wolozin, B., & Butterfield, D. A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.009 · Cited by 165
α-Synuclein Overexpression Increases Cytosolic Catecholamine Concentration
Mosharov, E. V., Staal, R. G. W., Bové, J., Prou, D., Hananiya, A., Markov, D., Poulsen, N., Larsen, K. E., Moore, C. M. H., Troyer, M. D., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0519-06.2006 · Cited by 165 · cited 2×
“2004) and membrane permeabilization (Rochet et al. 2004; Mosharov et al. 2006; Staal et al. 2008).”
BackgroundSelf-citationNeural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease
Blandini, F. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9435-y · Cited by 162
Carvey, P. M. (2003) · Frontiers in Bioscience · doi:10.2741/1158 · Cited by 161
Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review
Correia Guedes, L., Ferreira, J. J., Rosa, M. M., Coelho, M., Bonifati, V., & Sampaio, C. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.11.004 · Cited by 161
Chung, Y. C., Kim, S. R., & Jin, B. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000208 · Cited by 160
Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions.
McGeer, P. L., & McGeer, E. G. (1998) · PubMed · Cited by 158
Glial Cells as Players in Parkinsonism: The “Good,” the “Bad,” and the “Mysterious” Glia
Mena, M. A., & de Yébenes, J. G. (2008) · The Neuroscientist · doi:10.1177/1073858408322839 · Cited by 157
Oestreicher, E., Sengstock, G. J., Riederer, P., Olanow, C. W., Dunn, A. J., & Arendash, G. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)90833-8 · Cited by 156
Casarejos, M. J., Menéndez, J., Solano, R. M., Rodríguez‐Navarro, J. A., García de Yébenes, J., & Mena, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03777.x · Cited by 156
Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson’s disease
Ulusoy, A., Decressac, M., Kirik, D., & Björklund, A. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84005-1 · Cited by 155
Roy, A., Ghosh, A., Jana, A., Liu, X., Brahmachari, S., Gendelman, H. E., & Pahan, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038113 · Cited by 155
Couch, Y., Alvarez-Erviti, L., Sibson, N. R., Wood, M. J., & Anthony, D. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-166 · Cited by 155 · cited 1×
“Injection of monomeric or oligomeric α-syn into SN induced microgliosis (Wilms et al. 2009; Couch et al. 2011).”
BackgroundZhang, S., Wang, X.-J., Tian, L.-P., Pan, J., Lu, G.-Q., Zhang, Y.-J., Ding, J.-Q., & Chen, S.-D. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-154 · Cited by 154 · cited 3×
“…is provided by inhibiting inflammation with a peroxisome proliferator-activated receptor gamma agonist (Sadeghian et al. 2012), silencing theenzyme inducible nitricoxide synthase (iNOS) (Li et al. 2012)orblocking TNF-α (McCoy et al. 2006; Harms et al. 2011; Pabon et al. 2011; Zhang et al. 2011b).”
BackgroundThe many faces of alpha‐synuclein mutations
Kasten, M., & Klein, C. (2013) · Movement Disorders · doi:10.1002/mds.25499 · Cited by 154
Dusonchet, J., Kochubey, O., Stafa, K., Young, S. M., Zufferey, R., Moore, D. J., Schneider, B. L., & Aebischer, P. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5092-10.2011 · Cited by 150
Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
Esposito, E., Impellizzeri, D., Mazzon, E., Paterniti, I., & Cuzzocrea, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041880 · Cited by 144
Striatal Neuroinflammation Promotes Parkinsonism in Rats
Choi, D.-Y., Liu, M., Hunter, R. L., Cass, W. A., Pandya, J. D., Sullivan, P. G., Shin, E.-J., Kim, H.-C., Gash, D. M., & Bing, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005482 · Cited by 141
González, H., Contreras, F., Prado, C., Elgueta, D., Franz, D., Bernales, S., & Pacheco, R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203121 · Cited by 138
Graham, D. R., & Sidhu, A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22331 · Cited by 135
Emmer, K. L., Waxman, E. A., Covy, J. P., & Giasson, B. I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.247965 · Cited by 134
Unger, E. L., Eve, D. J., Perez, X. A., Reichenbach, D. K., Xu, Y., Lee, M. K., & Andrews, A. M. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.005 · Cited by 133
Cellular models to investigate biochemical pathways in Parkinson’s disease
Alberio, T., Lopiano, L., & Fasano, M. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08516.x · Cited by 131
ASSOCIATION BETWEEN EARLY-ONSET PARKINSON'S DISEASE AND MUTATIONS IN THE PARKIN GENE
Ücking, B. L., Onifati, V. I. B., Aughan, J. E. V., et al. (2000) · Cited by 129
Tanaka, S., Ishii, A., Ohtaki, H., Shioda, S., Yoshida, T., & Numazawa, S. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-143 · Cited by 128
Hoban, D. B., Connaughton, E., Connaughton, C., Hogan, G., Thornton, C., Mulcahy, P. J., Moloney, T. C., & Dowd, E. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.10.001 · Cited by 125
Paterna, J.-C., Leng, A., Weber, E., Feldon, J., & Büeler, H. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300067 · Cited by 125
Ghosh, A., Kanthasamy, A., Joseph, J., Anantharam, V., Srivastava, P., Dranka, B. P., Kalyanaraman, B., & Kanthasamy, A. G. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-241 · Cited by 125
Iravani, M. M., Leung, C. C. M., Sadeghian, M., Haddon, C. O., Rose, S., & Jenner, P. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04220.x · Cited by 123
Nitrated α-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats
Yu, Z., Xu, X., Xiang, Z., Zhou, J., Zhang, Z., Hu, C., & He, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009956 · Cited by 121
Perumal, A. S., Gopal, V. B., Tordzro, W. K., Cooper, T. B., & Cadet, J. L. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90142-k · Cited by 120 · cited 2×
“The toxin further decreases striatal glutathione and superoxide dismutase (Perumal et al. 1992; Kunikowska and Jenner 2001), increases iron in SN (Oestreicher et al.”
BackgroundCXCR4 and CXCL12 Expression is Increased in the Nigro-Striatal System of Parkinson’s Disease
Shimoji, M., Pagán, F., Healton, E. B., & Mocchetti, I. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9076-3 · Cited by 120
MAZZIO, E. A., Reams, R., & Soliman, K. F. A. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.034 · Cited by 118
Glial Dysfunction in Parkin Null Mice: Effects of Aging
Solano, R. M., Casarejos, M. J., Menéndez-Cuervo, J., Rodriguez-Navarro, J. A., García de Yébenes, J., & Mena, M. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4609-07.2008 · Cited by 117
Harms, A. S., Barnum, C. J., Ruhn, K. A., Varghese, S., Treviño, I., Blesch, A., & Tansey, M. G. (2011) · Molecular Therapy · doi:10.1038/mt.2010.217 · Cited by 116
Desai, V. G., Feuers, R. J., Hart, R. W., & Ali, S. F. (1996) · Brain Research · doi:10.1016/0006-8993(95)01255-9 · Cited by 115
Ling, Z. D., Chang, Q., Lipton, J. W., Tong, C. W., Landers, T. M., & Carvey, P. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.12.017 · Cited by 115
Zhang, Z., Cheang, L. C.-V., Wang, M.-W., Li, G., Chu, I. K., Lin, Z., & Lee, S. M. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9731-0 · Cited by 114
Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries
Henry, J., Smeyne, R. J., Jang, H., Miller, B., & Okun, M. S. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.06.012 · Cited by 110
Sanchez-Guajardo, V., Annibali, A., Jensen, P. H., & Romero-Ramos, M. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31829768d2 · Cited by 109
Wang, X.-J., Zhang, S., Yan, Z.-Q., Zhao, Y.-X., Zhou, H.-Y., Wang, Y., Lu, G.-Q., & Zhang, J.-D. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.032 · Cited by 108
The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease
Tufekci, K. U., Genc, S., & Genc, K. (2011) · Parkinson's Disease · doi:10.4061/2011/487450 · Cited by 107
Mangano, E. N., Litteljohn, D., So, R., Nelson, E., Peters, S., Bethune, C., Bobyn, J., & Hayley, S. P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.016 · Cited by 107
Lipopolysaccharide and Tumor Necrosis Factor Regulate Parkin Expression via Nuclear Factor-Kappa B
Tran, T. A., Nguyen, A. D., Chang, J., Goldberg, M., Lee, J., & Tansey, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023660 · Cited by 106
Liou, H., Chen, R.-C., Tsai, Y.-F., Chen, W., Chang, Y.-C., & Tsai, M.-C. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0054 · Cited by 105
Goes, A. T. R., Souza, L. C., Filho, C. B., Fabbro, L. D., de Gomes, M. G., Boeira, S. P., & Jessé, C. R. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.042 · Cited by 103
Genetic variants and animal models in SNCA and Parkinson disease
Deng, H., & Yuan, L. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.04.002 · Cited by 103
Deleidi, M., Hallett, P. J., Koprich, J. B., Chung, C.-Y., & Isacson, O. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2400-10.2010 · Cited by 101
Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice
Hunter, R. L., Cheng, B., Choi, D., Liu, M., Liu, S., Cass, W. A., & Bing, G. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22012 · Cited by 100
Modeling neuroinflammatory pathogenesis of Parkinson’s disease
Barnum, C. J., & Tansey, M. G. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84006-3 · Cited by 99
Zhou, H., Falkenburger, B. H., Schulz, J. B., Tieu, K., Xu, Z., & Xia, X. G. (2007) · International Journal of Biological Sciences · doi:10.7150/ijbs.3.242 · Cited by 99
Herva, M. E., Zibaee, S., Fraser, G. M., Barker, R. A., Goedert, M., & Spillantini, M. G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.542340 · Cited by 96
Coelln, R. V., Kügler, S., Bähr, M., Weller, M., Dichgans, J., & Schulz, J. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00236.x · Cited by 95
Cited by
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Self-citationα-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
Lindestam Arlehamn, C. S., Dhanwani, R., Pham, J., Kuan, R., Frazier, A., Rezende Dutra, J., Phillips, E., Mallal, S., Roederer, M., Marder, K. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15626-w · Cited by 386
Self-citationWerry, E. L., Bright, F. M., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kril, J. J., & Kassiou, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133161 · Cited by 279
Sulzer, D., Cassidy, C., Horga, G., Kang, U. J., Fahn, S., Casella, L., Pezzoli, G., Langley, J., Hu, X. P., Zucca, F. A., et al. (2018) · npj Parkinson's Disease · doi:10.1038/s41531-018-0047-3 · Cited by 270
Self-citation
Metadata
- Authors
- Cebrián, C., Loike, J. D., & Sulzer, D.
- Affiliations
- Columbia University Irving Medical Center (US)
- Corresponding author
- Sulzer, David
- Venue
- Current Topics in Behavioral Neurosciences
- Publisher
- Springer Berlin Heidelberg
- Published
- 2014
- Volume
- 22
- Pages
- 237-270
- ISSN
- 1866-3370 (ISSN-L)
- 1866-3389
- OpenAlex
- W2120150976
- Cited by
- 65
- References
- 282
- Citations by year
- 2025: 5 · 2024: 4 · 2023: 1 · 2022: 6 · 2021: 3 · 2020: 7 · 2019: 10 · 2018: 12 · 2017: 10 · 2016: 5 · 2015: 2
- FWCI
- 12.15
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Current topics in behavioral neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (P50NS038370)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, neuroinflammation, neurodegeneration, dopaminergic neurons, substantia nigra, glial activation, inflammatory cytokines, lymphocyte infiltration, cellular stress response, genetic animal models, behavioral symptoms
- MeSH terms
- Animals, Disease Models, Animal, Inflammation, Parkinson Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.